Skip to search.
 All Ordinaries Up0.25%

More On NRT.AX



News & Info


Analyst Coverage



Novogen Ltd (NRT.AX)

0.16 Down 0.01(3.12%) 8 Oct 16:10
ProfileGet Profile for:
Novogen Ltd
16-20 Edgeworth David Avenue
Level 1
Hornsby, NSW 2077
Australia - Map
Phone: 61 2 9472 4100
Fax: 61 2 9476 0388

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). Its SBP technology platform offers Cantrixil, an intra-cavity anti-cancer agent for the treatment of ovarian cancer, malignant ascites, and malignant pleural effusion; and Trilexium for the treatment of brain cancers, neuroblastoma, and melanoma. Its ATM technology platform provides Anisina that destructs cancer cells cytoskeleton. The company is also developing various programs in the areas of regenerative medicine, facioscapulohumeral muscular dystrophy, and lysosomal storage disorder. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.

Key Statistics

Company Websites 
Home Page
Search Yahoo!7 for:
More on Novogen Ltd

Key Executives 
Mr. Iain Gladstone Ross B.Sc. (HONS), C.DIR , 61
Acting Chief Exec. Officer and Director
Christine Bruce ,
Acting Chief Financial Officer
Dr. David Brown B.App. Sc. (Hons), Ph.D., GradDip,
Chief Scientific Officer
Ms. Cristyn Humphreys BBUS(ACC), DIPPOL, FTI, CA ,
Chief Operating Officer of Admin. and Fin.
Mr. Lionel Mateo BCL MCL,
Company Sec.
Dr. Andrew Heaton B.Sc (Hons) Ph.D.,
Vice-Pres of Drug Discovery, Manufacture & Patents
Amounts are as of 31/12/2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.
View Insiders